JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹407.3 Cr | 0.9% | -6.7% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 0.9% |
-6.7% |
-13.4% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses